General Hospital Of Shenyang Military Region
Clinical trials sponsored by General Hospital Of Shenyang Military Region, explained in plain language.
-
Double dose hope: new stroke treatment aims to unblock arteries faster
Disease control Not yet recruitingThis study looks at giving an extra dose of the clot-busting drug prourokinase to people having a stroke caused by a medium or large blocked artery. Participants must not have improved much one hour after the first standard treatment. The goal is to see if the second dose can ope…
Phase: PHASE2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
Which drug saves kidneys in liver bleeding emergencies?
Disease control Not yet recruitingThis study compares two medications, terlipressin and somatostatin, in 64 adults with liver cirrhosis who have both acute gastrointestinal bleeding and acute kidney injury. The goal is to see which drug better reverses the kidney damage. Participants will be randomly assigned to …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated May 11, 2026 20:53 UTC